We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Fourth quarter and full year 2025 results
February 04, 2026 | Basel, Switzerland
Watch the webcast
14:00 CET | 13:00 GMT | 08:00 EST
Investors event calendar
View recent presentations and learn more about upcoming events.
February 04, 2026
Fourth quarter and full year results 2025
Basel, Switzerland
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: November 2025 (PDF 0.8 MB) | July 2025 (PDF 0.8 MB) | May 2025 (PDF 0.9 MB) | February 2025 (PDF 1.0 MB)
Latest updates: Social Impact & Sustainability(PDF 2.1 MB) | Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.